Literature DB >> 15501926

Ascorbic acid does not affect the age-associated reduction in maximal cardiac output and oxygen consumption in healthy adults.

Christopher Bell1, John M Carson, Nathaniel W Motte, Douglas R Seals.   

Abstract

Maximal aerobic capacity (Vo(2max)) decreases progressively with age, primarily because of a reduction in maximal cardiac output (Q(max)). This age-associated decline in Vo(2max) may be partially mediated by the development of oxidative stress that can suppress beta-adrenergic-receptor responsiveness and, consequently, reduce Q(max). To test this hypothesis, Vo(2max) (indirect calorimetry) and Q(max) (open-circuit acetylene breathing) were determined in 12 young (23 +/- 1 yr, mean +/- SE) and 10 older (61 +/- 1 yr) adults following systemic infusion of either saline (control) and/or the powerful antioxidant ascorbic acid (acute: bolus 0.06; drip 0.02 g/kg fat-free mass) and following chronic 30-day oral administration of ascorbic acid (500 mg/day). Plasma ascorbic acid concentration was not different between young and older adults and was increased similarly, independent of age [change (Delta) acute = 1,055 +/- 117%; Delta chronic = 62 +/- 19%]. Oxidized low-density lipoprotein concentration was greater (P < 0.001) in older (57 +/- 5 U/l) compared with young (34 +/- 3 U/l) adults and was reduced in both groups (P < 0.02) following acute (Delta = -6 +/- 2%) but not chronic (P = 0.18) ascorbic acid administration. Control (baseline) Vo(2max) and Q(max) were positively related (r = 0.76, P < 0.001) and were lower (P < 0.05) in older (34 +/- 2 ml.kg(-1).min(-1); 16.1 +/- 1.1 l/min) compared with young (43 +/- 3 ml.kg(-1).min(-1); 20.2 +/- 0.9 l/min) adults. Following ascorbic acid administration, neither Vo(2max) (young acute = 41 +/- 2; young chronic = 42 +/- 2; older acute = 34 +/- 2; older chronic = 34 +/- 2 ml.kg(-1).min(-1)) nor Q(max) (young acute = 20.1 +/- 0.9; young chronic = 19.1 +/- 0.8; older acute = 16.2 +/- 1.1; older chronic = 16.6 +/- 1.4 l/min) was changed. These data suggest that ascorbic acid administration does not affect the age-associated reduction in Q(max) and Vo(2max).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501926     DOI: 10.1152/japplphysiol.00790.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Thermogenic responsiveness to beta-adrenergic stimulation is augmented in exercising versus sedentary adults: role of oxidative stress.

Authors:  Christopher Bell; Nicole R Stob; Douglas R Seals
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

2.  Acute ascorbic acid ingestion increases skeletal muscle blood flow and oxygen consumption via local vasodilation during graded handgrip exercise in older adults.

Authors:  Jennifer C Richards; Anne R Crecelius; Dennis G Larson; Frank A Dinenno
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-15       Impact factor: 4.733

3.  Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans.

Authors:  Jennifer C Richards; Mark C Lonac; Tyler K Johnson; Melani M Schweder; Christopher Bell
Journal:  Med Sci Sports Exerc       Date:  2010-04       Impact factor: 5.411

4.  Effect of antioxidants on histamine receptor activation and sustained postexercise vasodilatation in humans.

Authors:  Steven A Romero; Matthew R Ely; Dylan C Sieck; Meredith J Luttrell; Tahisha M Buck; Jordan M Kono; Adam J Branscum; John R Halliwill
Journal:  Exp Physiol       Date:  2015-03-25       Impact factor: 2.969

Review 5.  Vitamin C supplementation in the critically ill: A systematic review and meta-analysis.

Authors:  Michael Zhang; David F Jativa
Journal:  SAGE Open Med       Date:  2018-10-19

6.  Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.

Authors:  Janelle L Davis; Hunter L Paris; Joseph W Beals; Scott E Binns; Gregory R Giordano; Rebecca L Scalzo; Melani M Schweder; Emek Blair; Christopher Bell
Journal:  Nutr Metab Insights       Date:  2016-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.